Kutahya Seker Fabrikasi Anonim Sirketi (IST:KTSKR)
Turkey flag Turkey · Delayed Price · Currency is TRY
67.65
+0.80 (1.20%)
Last updated: Aug 13, 2025

CTI BioPharma Revenue

Kutahya Seker Fabrikasi Anonim Sirketi had revenue of 377.73M TRY in the quarter ending June 30, 2025, with 104.55% growth. This brings the company's revenue in the last twelve months to 2.02B, down -14.41% year-over-year. In the year 2024, Kutahya Seker Fabrikasi Anonim Sirketi had annual revenue of 1.94B, down -19.92%.

Revenue (ttm)
2.02B
Revenue Growth
-14.41%
P/S Ratio
1.53
Revenue / Employee
6.70M
Employees
328
Market Cap
3.10B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.94B-483.17M-19.92%
Dec 31, 20232.43B1.87B335.41%
Dec 31, 2022557.03M291.38M109.69%
Dec 31, 2021265.65M39.56M17.50%
Dec 31, 2020226.09M32.93M17.05%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition